1. Haroun, MW, Dieiev, V, Kang, J, et al. Rhabdomyolysis in COVID-19 patients: a retrospective observational study. Cureus 2021; 1: e12552.
Google Scholar2. WHO . Coronavirus disease 2019 (COVID-19) Situation Dashboard. https://covid19.who.int(Accessed 01 July 2021).
Google Scholar3. Mithal, A, Jevalikar, G, Sharma, R, et al. High prevalence of diabetes and other comorbidities in hospitalized patients with COVID-19 in Delhi, India, and their association with outcomes. Diabetes Metab Syndr 2021; 1: 169–175.
Google Scholar | Crossref4. Lippi, G, Wong, J, Henry, BM. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med 2020; 130: 304–309.
Google Scholar | Medline5. Clinical management of Severe Acute Respiratory Infection when Novel Coronavirus (2019-nCoV) Infection Is Suspected: Interim Guidance, https://apps.who.int/iris/handle/10665/330893 (Accessed 8 January 2020)
Google Scholar6. James, PA, Oparil, S, Carter, BL, et al. evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). J Am Med Assoc 2014; 5: 507–520.2014
Google Scholar | Crossref7. Williams, B, Mancia, G, Spiering, W, et al. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 33: 3021–3104.
Google Scholar | Crossref8. Karahasan Yagci, A, Sarinoglu, RC, Bilgin, H, et al. Relationship of the cycle threshold values of SARS-CoV-2 polymerase chain reaction and total severity score of computerized tomography in patients with COVID 19. Int J Infect Dis 2020; 101: 160–166.
Google Scholar | Crossref | Medline9. Medetalibeyoglu, A, Emet, S, Kose, M, et al. Serum endocan levels on admission are associated with worse clinical outcomes in COVID-19 patients: a pilot study. Angiology 2021; 2: 187–193.
Google Scholar | SAGE Journals10. Wan, S, Yi, Q, Fan, S, et al. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients. Br J Haematol 2020; 3: 428–437.
Google Scholar | Crossref11. Qin, C, Zhou, L, Hu, Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 2020; 15: 762–768.
Google Scholar | Crossref12. Imam, Z, Odish, F, Gill, I, et al. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. J Intern Med 2020; 4: 469–476.
Google Scholar | Crossref13. Tadic, M, Cuspidi, C, Grassi, G, Mancia, G. COVID‐19 and arterial hypertension: hypothesis or evidence? J Clin Hypertens 2020; 22: 1120–1126.
Google Scholar | Crossref14. Sanlialp, SC, Sanlialp, M. Impact of hypertension on the prognosis of COVID-19 disease and uncertainties that need to be clarified. Angiology 2021; 14: 33197211032784. doi:10.1177/00033197211032784.
Google Scholar | SAGE Journals15. Momtazi-Borojeni, AA, Banach, M, Reiner, Ž, et al. Interaction between coronavirus s-protein and human ACE2: hints for exploring efficient therapeutic targets to treat COVID-19. Angiology 2021; 2: 122–130.
Google Scholar | SAGE Journals16. Iheanacho, CO, Odili, VU, Eze, UIH. Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin-angiotensin-aldosterone system (RAAS) inhibitors: a systematic review. Future J Pharm Sci 2021; 7: 73.
Google Scholar | Crossref | Medline17. Bozkurt, B, Kovacs, R, Harrington, B. Joint HFSA/ACC/AHA statement addresses concerns Re: using RAAS antagonists in COVID-19. J Card Fail 2020; 26: 370.
Google Scholar | Crossref | Medline18. European Societies of Cardiology . Position Statement of ESC Council on Hypertension on ACE Inhibitors and Angiotensin Receptor Blockers. https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang (Accessed 13 March 2020)
Google Scholar19. Gheblawi, M, Wang, K, Viveiros, A, et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res 2020; 10: 1456–1474.
Google Scholar | Crossref20. Patel, VB, Zhong, J-C, Grant, MB, Oudit, GY. Role of the ACE2/Angiotensin 1-7 axis of the renin-angiotensin system in heart failure. Circ Res 2016; 118: 1313–1326.
Google Scholar | Crossref | Medline | ISI21. Wang, K, Gheblawi, M, Oudit, GY. Angiotensin converting enzyme 2. Circulation 2020; 142: 426–428.
Google Scholar | Crossref | Medline22. Liu, Y, Yang, Y, Zhang, C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 2020; 3: 364–374.
Google Scholar | Crossref23. Athyros, VG, Doumas, M. A possible case of hypertensive crisis with intracranial haemorrhage after an mRNA anti-COVID-19 vaccine. Angiology 2021 May 21: 33197211018323.
Google Scholar | Medline24. Meylan, S, Livio, F, Foerster, M, Genoud, PJ, Marguet, F, Wuerzner, G, CHUV COVID Vaccination Center. Stage III hypertension in patients after mRNA-based SARS-CoV-2 vaccination. Hypertension 2021; 77: e56–e57.
Google Scholar | Crossref | Medline25. Hippisley-Cox, J, Patone, M, Mei, XW, et al. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ 2021; 374: n1931.
Google Scholar | Crossref | Medline